2 years ago
ABBV
AnalystsSteve ChesneySteve Chesney's Stock Forecasts
AnalystsSteve Chesney
Analyst Ranking
Bottom 16%
#3841 out of 4559 analysts
Average Return
-1.58%
Win Rate
52%12 out of 23
Risk vs Reward
Poor
Good
Steve Chesney's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Idexx Laboratories IncIDXX | +39.32% | $372.64 | $519.18 | 2022-11-01 - 2023-08-02 | Strong Buy |
Idexx Laboratories IncIDXX | +27.60% | $406.87 | $519.18 | 2022-08-02 - 2023-08-02 | Strong Buy |
Abbvie IncABBV | +17.15% | $97.31 | $114.00 | 2020-06-22 - 2021-06-23 | Strong Buy |
Idexx Laboratories IncIDXX | +15.19% | $450.70 | $519.18 | 2023-06-06 - 2023-08-02 | Strong Buy |
Merck & Co IncMRK | +14.61% | $93.77 | $107.47 | 2022-07-12 - 2023-07-12 | Strong Buy |
Steve Chesney Analyst Color
Get additional color on Steve Chesney's coverage of popular stocks
Steve Chesney's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bristol Myers Squibb CoBMY | 7 | Hold | $54.00 | +9.89% | Downgrades | 3 months ago |
Biogen IncBIIB | 5 | Hold | $275.00 | +41.67% | Maintains | 8 months ago |
Johnson & JohnsonJNJ | 6 | Hold | $170.00 | +14.00% | Maintains | 9 months ago |
Idexx Laboratories IncIDXX | 6 | Hold | $600.00 | +25.11% | Downgrades | 9 months ago |
Zoetis IncZTS | 2 | Strong Buy | $225.00 | +54.60% | Reiterates | 10 months ago |
Merck & Co IncMRK | 5 | Strong Buy | $129.00 | +1.62% | Maintains | a year ago |
Abbvie IncABBV | 4 | Hold | $154.00 | N/A | Maintains | a year ago |
Pfizer IncPFE | 2 | Hold | $46.00 | N/A | Maintains | a year ago |
Amgen IncAMGN | 2 | Strong Sell | $182.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.